Terms: = Sarcomas AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Treatment
136 results:
1. Primary breast rhabdomyosarcoma in a 17-year-old girl.
Singotia L; Haritha VS
J Cancer Res Ther; 2023 Oct; 19(7):2070-2071. PubMed ID: 38376322
[TBL] [Abstract] [Full Text] [Related]
2. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
3. Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
Benhima N; Belbaraka R; Langouo Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):69-73. PubMed ID: 38193381
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.
Ding M; Ran X; Qian S; Zhang Y; Wang Z; Dong M; Yang Z; Wu S; Feng X; Zhang J; Zhu L; Niu S; Zhang X
Aging (Albany NY); 2023 Dec; 15(24):15360-15381. PubMed ID: 38180104
[TBL] [Abstract] [Full Text] [Related]
5. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Ascierto PA; Casula M; Bulgarelli J; Pisano M; Piccinini C; Piccin L; Cossu A; Mandalà M; Ferrucci PF; Guidoboni M; Rutkowski P; Ferraresi V; Arance A; Guida M; Maiello E; Gogas H; Richtig E; Fierro MT; Lebbe C; Helgadottir H; Queirolo P; Spagnolo F; Tucci M; Del Vecchio M; Cao MG; Minisini AM; De Placido S; Sanmamed MF; Mallardo D; Paone M; Vitale MG; Melero I; Grimaldi AM; Giannarelli D; Dummer R; Sileni VC; Palmieri G
Nat Commun; 2024 Jan; 15(1):146. PubMed ID: 38167503
[TBL] [Abstract] [Full Text] [Related]
6. Single protein encapsulated SN38 for tumor-targeting treatment.
Yu C; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
J Transl Med; 2023 Dec; 21(1):897. PubMed ID: 38072965
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
[TBL] [Abstract] [Full Text] [Related]
8. Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma.
Koseła-Paterczyk H; Rutkowski P
Expert Opin Biol Ther; 2023 May; 23(5):383-388. PubMed ID: 37200112
[TBL] [Abstract] [Full Text] [Related]
9. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
10. [Not Available].
Galicier L; Schleinitz N
Rev Med Interne; 2022 Dec; 43(10S1):10S26-10S33. PubMed ID: 36657940
[TBL] [Abstract] [Full Text] [Related]
11. Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient.
Yuan LL; Chen Z; Qin J; Qin CJ; Bian J; Dong RF; Yuan TB; Xu YT; Kong LY; Xia YZ
Front Immunol; 2022; 13():1019870. PubMed ID: 36466840
[TBL] [Abstract] [Full Text] [Related]
12. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
13. Single-cell RNA-sequencing dissects cellular heterogeneity and identifies two tumor-suppressing immune cell subclusters in HPV-related cervical adenosquamous carcinoma.
Li X; Zhang M; Lei T; Zou W; Huang R; Wang F; Huang Q; Wang C; Liu C
J Med Virol; 2022 Dec; 94(12):6047-6059. PubMed ID: 36000446
[TBL] [Abstract] [Full Text] [Related]
14. Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential.
Wen Y; Tang F; Tu C; Hornicek F; Duan Z; Min L
Cancer Lett; 2022 Oct; 547():215887. PubMed ID: 35995141
[TBL] [Abstract] [Full Text] [Related]
15. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Somaiah N; Conley AP; Parra ER; Lin H; Amini B; Solis Soto L; Salazar R; Barreto C; Chen H; Gite S; Haymaker C; Nassif EF; Bernatchez C; Mitra A; Livingston JA; Ravi V; Araujo DM; Benjamin R; Patel S; Zarzour MA; Sabir S; Lazar AJ; Wang WL; Daw NC; Zhou X; Roland CL; Cooper ZA; Rodriguez-Canales J; Futreal A; Soria JC; Wistuba II; Hwu P
Lancet Oncol; 2022 Sep; 23(9):1156-1166. PubMed ID: 35934010
[TBL] [Abstract] [Full Text] [Related]
16. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
[TBL] [Abstract] [Full Text] [Related]
17. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract] [Full Text] [Related]
18. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
[TBL] [Abstract] [Full Text] [Related]
19. New Approaches Promise to Improve Local Ewing Sarcoma Results.
Cohen IJ; Ash S
J Pediatr Hematol Oncol; 2022 Aug; 44(6):280-284. PubMed ID: 35537008
[TBL] [Abstract] [Full Text] [Related]
20. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
Münz C
J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
[TBL] [Abstract] [Full Text] [Related]
[Next]